Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

VYNE Therapeutics Inc (NASDAQ: VYNE)

 
VYNE Technical Analysis
5
As on 9th Jun 2023 VYNE SHARE Price closed @ 5.27 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.48 & Strong Buy for SHORT-TERM with Stoploss of 0.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VYNESHARE Price

Open 5.60 Change Price %
High 5.84 1 Day -0.52 -8.98
Low 5.27 1 Week -1.33 -20.15
Close 5.27 1 Month 0.80 17.90
Volume 16478 1 Year 4.19 387.96
52 Week High 8.66 | 52 Week Low 0.12
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VYNE
Daily Charts		 VYNE
Intraday Charts		 Whats New @
Bazaartrend		 VYNE
Free Analysis
 
VYNE Important Levels Intraday
RESISTANCE6.37
RESISTANCE6.02
RESISTANCE5.80
RESISTANCE5.58
SUPPORT4.96
SUPPORT4.74
SUPPORT4.52
SUPPORT4.17
 
VYNE Forecast April 2024
Share
4th UP Forecast6.5
3rd UP Forecast6.11
2nd UP Forecast5.86
1st UP Forecast5.62
1st DOWN Forecast4.92
2nd DOWN Forecast4.68
3rd DOWN Forecast4.43
4th DOWN Forecast4.04
 
VYNE Weekly Forecast
4th UP Forecast5.58
3rd UP Forecast5.48
2nd UP Forecast5.42
1st UP Forecast5.36
1st DOWN Forecast5.18
2nd DOWN Forecast5.12
3rd DOWN Forecast5.06
4th DOWN Forecast4.96
 
VYNE Forecast2024
4th UP Forecast21.88
3rd UP Forecast16.55
2nd UP Forecast13.26
1st UP Forecast9.97
1st DOWN Forecast0.57
2nd DOWN Forecast-2.72
3rd DOWN Forecast-6.01
4th DOWN Forecast-11.34
 
 
VYNE Other Details
Segment EQ
Market Capital 65935104.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VYNE Address
VYNE
 
VYNE Latest News
 
Your Comments and Response on VYNE Therapeutics Inc
 
VYNE Business Profile
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey. Address: 520 U.S. Highway 22, Bridgewater, NJ, United States, 08807
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service